ROS-dependent activation of JNK converts p53 into an efficient inhibitor of oncogenes leading to robust apoptosis

Y. Shi , F. Nikulenkov , Joanna Zawacka-Pankau , H. Li , R. Gabdoulline , J. Xu , S. Eriksson , E. Hedström , N. Issaeva , A. Kel , E. S. J. Arnér , G. Selivanova

Abstract

n/a
Author Y. Shi
Y. Shi,,
-
, F. Nikulenkov
F. Nikulenkov,,
-
, Joanna Zawacka-Pankau KB
Joanna Zawacka-Pankau,,
- Department of Biotechnology
, H. Li
H. Li,,
-
, R. Gabdoulline
R. Gabdoulline,,
-
, J. Xu
J. Xu,,
-
, S. Eriksson
S. Eriksson,,
-
, E. Hedström
E. Hedström,,
-
, N. Issaeva
N. Issaeva,,
-
, A. Kel
A. Kel,,
-
et al.
Journal seriesCell Death and Differentiation, ISSN 1350-9047
Issue year2014
Vol21
No4
Pages612-623
Keywords in EnglishTrxR, ROS, JNK, p53, Wip1, inhibition of oncogenes
DOIDOI:10.1038/cdd.2013.186
URL http://www.nature.com/cdd/journal/v21/n4/pdf/cdd2013186a.pdf
Languagepl polski
LicenseJournal (articles only); published final; Uznanie Autorstwa - Użycie Niekomercyjne - Na tych samych warunkach (CC-BY-NC-SA); with publication
Score (nominal)40
ScoreMinisterial score = 40.0, 20-12-2017, ArticleFromJournal
Ministerial score (2013-2016) = 40.0, 20-12-2017, ArticleFromJournal
Publication indicators WoS Impact Factor: 2014 = 8.184 (2) - 2014=8.461 (5)
Citation count*0
Cite
Share Share



* presented citation count is obtained through Internet information analysis and it is close to the number calculated by the Publish or Perish system.
Back